(A top pick Oct 15/03. Up 7½%.) Still likes and would still buy at this price. Increasing their CapX next year by 15%, which is a very positive move as it speaks to the rate of return and opportunities they have.

(A top pick Oct 15/03. Up 9½%.) A better environment for the mutual funds now. Not as many redemptions are occurring.

(A top pick Oct 15/03. Up 3%.) Continue to like this. Sophisticated in identifying where they make money and what kind of people. An improvement in the pricing cycle. Would continue to buy.

There are a lot of investigations going on. Too much uncertainty. A speculative stock.

Acquisition of John Hancock was a good move. A risk will be if John Hancock shareholders decide to sell their shares, but Manulife has a pretty strong buyback position on this. An interesting stock. Well-positioned for the long term.

Missed two quarters in a row in their earnings estimates. The stock is in a “ shown me” mode. Until they can get a couple of quarters meeting expectations, the stock could tread water. Not expensive.

A good investment. Should continue to do well.